CoChat

Modelling the long QT syndrome with induced pluripotent stem cells

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.

Overview

Integrity signals

Registry

Crossref · 10.1038/nature09747

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 1,049

Metadata

Authors
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
Affiliations
Technion – Israel Institute of Technology (IL)
Corresponding author
Gepstein, Lior
Venue
Nature
Published
2011-01-16
Volume
471
Issue
7337
Pages
225-229
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2115644752
Cited by
1,049
References
28
Citations by year
2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
FWCI
86.57
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
Israel Science Foundation
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Keywords
long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
MeSH terms
ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.